BioNTech SE Working Capital to Net Assets Ratio
BioNTech SE working capital to net assets ratio. BioNTech SE (22UA) has a Working Capital to Net Assets ratio of 73.6% as of March 2026. Working capital of €13.77 Billion (current assets of €15.53 Billion minus current liabilities of €1.76 Billion) is measured against net assets of €18.70 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of BioNTech SE to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of BioNTech SE (2016–2025)
Working capital to net assets ratio of BioNTech SE from 2016 to 2025. This chart shows how BioNTech SE's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 73.6%, reflecting working capital of €13.77 Billion against net assets of €18.70 Billion EUR. See BioNTech SE (22UA) liquidity interval to measure how many days the company can operate on defensive assets alone.
BioNTech SE Working Capital to Net Assets Ratio by Year (2016–2025)
BioNTech SE working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for BioNTech SE from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BioNTech SE assets under control.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 72.8% | €14.00 Billion | €19.22 Billion | €16.15 Billion | €2.14 Billion | ▼ -11.0 pp |
| 2024 | 83.9% | €16.28 Billion | €19.41 Billion | €18.80 Billion | €2.52 Billion | ▼ -2.4 pp |
| 2023 | 86.2% | €17.46 Billion | €20.25 Billion | €19.53 Billion | €2.07 Billion | ▼ -8.4 pp |
| 2022 | 94.6% | €18.97 Billion | €20.06 Billion | €21.92 Billion | €2.95 Billion | ▼ -2.9 pp |
| 2021 | 97.5% | €11.59 Billion | €11.89 Billion | €15.07 Billion | €3.48 Billion | ▲ +20.1 pp |
| 2020 | 77.3% | €1.06 Billion | €1.37 Billion | €1.67 Billion | €606.00 Million | ▼ -8.2 pp |
| 2019 | 85.5% | €422.01 Million | €493.49 Million | €560.15 Million | €138.14 Million | ▼ -35.4 pp |
| 2018 | 120.9% | €322.84 Million | €267.00 Million | €448.96 Million | €126.12 Million | ▲ +185.4 pp |
| 2017 | -64.5% | €31.09 Million | €-48.21 Million | €189.64 Million | €158.54 Million | ▼ -885.3 pp |
| 2016 | 820.8% | €261.49 Million | €31.86 Million | €318.12 Million | €56.64 Million | — |